CAS NO: | 188627-80-7 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | Eptifibatide is a cyclic heptapeptide, acts as a competitive antagonist for the activated plateletglycoprotein IIb/IIIareceptor, with anti-platelet activity[1]. | ||||||||||||||||
体外研究 (In Vitro) | Eptifibatide is a cyclic heptapeptide, acts as a competitive antagonist for the activated platelet glycoprotein IIb/IIIa receptor, with anti-platelet activity[1]. | ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 831.96 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C35H49N11O9S2 | ||||||||||||||||
CAS 号 | 188627-80-7 | ||||||||||||||||
Sequence | MPA-HAR-Gly-Asp-Trp-Pro-Cys-NH2 | ||||||||||||||||
Sequence Shortening | MPA-HAR-GDWPC-NH2 | ||||||||||||||||
中文名称 | 埃替非巴肽;依非巴特;安普利肽;依菲巴特;依替巴肽 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | Sealed storage, away from moisture and light
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) | ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 250 mg/mL(300.50 mM;Need ultrasonic) H2O : 50 mg/mL(60.10 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|